Corrigendum to “Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyˮ [Eur J Canc 144 (2021) 341–350]
Titel:
Corrigendum to “Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyˮ [Eur J Canc 144 (2021) 341–350]
Auteur:
Jeong, Jae Ho Kim, Jeong Eun Ahn, Jin-Hee Jung, Kyung Hae Koh, Su-Jin Cheon, Jaekyung Sohn, Joohyuk Kim, Gun Min Lee, Keun Seok Sim, Sung Hoon Park, In Hae Kim, Sung-Bae